LONDON, Feb. 9 -- The Government of UK issued details related to the following business opportunity:
Contracting Authority: University of Bristol
Industry: Medical equipments, pharmaceuticals and personal care products
Description: MRC Sleep Study - Purchase of IMP to include the following activities: - Support with regulatory approvals (preparation of IMPD) - Sourcing of Trazodone 100mg tablets & Zolpidem 5mg tablets - Over-encapsulation of active products & Manufacture of matched placebo capsules) - Packaging of products in to bottles, designing and providing blinded labels in accordance with Medicines for Human Use (Clinical Trials) Regulations 2004 and the 2025 Amendment to Regulations - Hold appropriate MIA(IMP) authorisation - QP Certification for use in the UK - Storage & Distribution to UK Pharmacy - Ensure full traceability of materials and processes, including batch release certificates and audit trails - Conducting such work as instructed, and in accordance with any relevant protocol / policy / work-instruction, for the duration of the contract. - Compliance with Medicines for Human Use (Clinical Trials) Regulations 2004 and the 2025 Amendment to Regulations when they are applied in April 2026 plus any other applicable regulatory requirements
Closing date: 2026-03-06T12:00:00Z
Contract duration: 2026-06-30T00:00:00+01:00 to 2029-12-31T00:00:00Z
Value of contract: GBP151000
Location of contract: South West
About the buyer: Louise Parton; louise.parton@bristol.ac.uk; 4th Floor, Augustine's Courtyard, Orchard Lane, Bristol, BS1 5DS; Bristol; BS1 5DS; England
Disclaimer: Curated by HT Syndication.
